北京元六鸿远电子科技股份有限公司 2024 年年度股东会会议资料 北京元六鸿远电子科技股份有限公司 2024 年年度股东会 会议资料 2025 年 4 月 17 日 1 北京元六鸿远电子科技股份有限公司 2024 年年度股东会会议资料 北京元六鸿远电子科技股份有限公司 2024 年年度股东会文件目录 | 2024 年年度股东会会议议程 3 | | --- | | 2024 年年度股东会须知 5 | | 《关于公司 2024 年度董事会工作报告的议案》 6 | | 《关于公司 2024 年度监事会工作报告的议案》 12 | | 《关于公司 2024 年度独立董事述职报告的议案》 16 | | 《关于公司 2024 年年度报告全文及摘要的议案》 17 | | 《关于公司 2024 年度利润分配预案的议案》 18 | | 《关于独立董事 年度薪酬确认及 2024 2025 年度薪酬方案的议案》 20 | | 《关于非独立董事 2024 年度薪酬确认及 2025 年度薪酬方案的议案》 21 | | 《关于监事 年度薪酬确认及 年度薪酬方案的议案》 22 2024 2025 | | 《关于公司续聘会计师事务所的议案》 ...

Group 1 - The company, Beijing Yuanliu Hongyuan Electronics Technology Co., Ltd., plans to hold its 2024 annual shareholders' meeting on April 17, 2025, at 14:00, utilizing a combination of on-site and online voting methods [1] - The company aims to enhance service for small and medium investors by using Shanghai Stock Exchange Information Co., Ltd. to provide shareholder meeting reminder services, ensuring timely participation and convenient voting [2] - Investors will receive proactive notifications about the meeting and voting options through smart SMS, and they can vote directly via the provided user manual or through existing trading and internet voting platforms [2]

北京元六鸿远电子科技股份有限公司董事会 2025 年 4 月 8 日 北京元六鸿远电子科技股份有限公司（以下简称"公司"）拟于 2025 年 4 月 17 日 14:00 召开 2024 年年度股东会，本次会议采用现场投票和网络投票相结合 的表决方式。具体内容请详见公司 2025 年 3 月 28 日披露于上海证券交易所网站 （http://www.sse.com.cn）及指定信息披露媒体的《鸿远电子关于召开 2024 年年 度股东会的通知》（公告编号：临 2025-015）。 为更好地服务广大中小投资者，确保有投票意愿的中小投资者能够及时参会、 便利投票。公司拟使用上证所信息网络有限公司（以下简称"上证信息"）提供 的股东会提醒服务，委托上证信息通过智能短信等形式，根据股权登记日的股东 名册主动提醒股东参会投票，向每一位投资者主动推送股东会参会邀请、议案情 况等信息。投资者在收到智能短信后，可根据《上市公司股东会网络投票一键通 服务用户使用手册》（https://vote.sseinfo.com/i/yjt_help.pdf）的提示步骤直接投票， 如遇拥堵等情况，仍可通过原有的交易系统投票平台和互联网投票平 ...

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company has reported a revenue of 1.492 billion yuan for 2024, a year-on-year decrease of 10.98%, and a net profit attributable to shareholders of 154 million yuan, down 43.55% year-on-year [2] - The demand in the industry has fully recovered, with significant order growth from upstream component manufacturers, particularly in the MLCC sector [3] - The company is expected to benefit from a new round of military orders, with a substantial increase in demand for high-reliability ceramic capacitors [3] - The average price of high-reliability capacitors has decreased by approximately 20% compared to the previous year, impacting the gross margin [4] - The company is expanding its product categories and applications, particularly in military and aerospace sectors, which are expected to drive future growth [5][6] - The global military expenditure reached a record high of 2.443 trillion USD in 2024, indicating a potential increase in military trade demand [7] - The commercial aerospace sector is anticipated to experience significant growth in 2025, with the company positioned to benefit from increased satellite launches and related electronic component demand [8][9] Financial Summary - The company’s projected revenues for 2025, 2026, and 2027 are 2.097 billion yuan, 2.629 billion yuan, and 3.138 billion yuan respectively, with year-on-year growth rates of 40.6%, 25.3%, and 19.4% [10][14] - The net profit for the same years is expected to be 354 million yuan, 501 million yuan, and 604 million yuan, with growth rates of 130.4%, 41.5%, and 20.5% respectively [10][14] - The earnings per share (EPS) are projected to be 1.53 yuan, 2.17 yuan, and 2.61 yuan for 2025, 2026, and 2027 respectively [10][14] - The company maintains a healthy financial position with a projected gross margin recovery as delivery volumes increase [4][10]

Group 1: Baili Tianheng - In 2024, Baili Tianheng achieved operating revenue of 582.27 million yuan, a year-on-year increase of 936.31%, and net profit of 370.75 million yuan, turning a profit [1] - The company received an $800 million upfront payment from BMS as part of its innovative oncology drug combination [1] - Multiple clinical trials for BL-B01D1 are ongoing in China and the U.S., including several Phase III trials [1] - The company plans to increase R&D investment to 1.443 billion yuan in 2024 and continue to expand in 2025 [1] Group 2: Teabo Bio - Teabo Bio's application for the marketing authorization of Pegbivac is currently under technical review after being accepted in March 2024 [2] - The company is also advancing the registration of long-acting growth hormone and SKG0201, with applications accepted in January 2024 [2] - Teabo Bio emphasizes the strategic significance of acquiring Jiutian Bio and plans to increase R&D investment focusing on breakthrough technology platforms [2] Group 3: Hongyuan Electronics - In 2024, Hongyuan Electronics experienced an 8.57 percentage point decline in gross margin due to falling prices of high-reliability ceramic capacitors and an increase in low-margin product sales [3] - The company reported a 56.11% revenue growth in microcontrollers and integrated circuit products [3] - Major clients account for 71.09% of sales revenue, primarily from China Electronics Technology Group [3] Group 4: Lens Technology - Lens Technology is rapidly developing in automotive, smart terminal, and humanoid robot sectors, collaborating with over 30 smart car brands [4] - The company expects significant growth in its smart retail terminal business and aims to become a core manufacturing platform for embodied intelligent hardware [4] - Lens Technology has made progress in developing ultra-thin laminated glass for automotive applications, with expectations to introduce it to leading domestic new energy vehicle brands this year [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 1.492 billion yuan for 2024, a year-on-year decrease of 10.98%, and a net profit attributable to shareholders of 154 million yuan, down 43.55% year-on-year [1][8] - The decline in performance is attributed to a slow recovery in the downstream market, particularly in the high-reliability sector, which has led to decreased sales and prices of the company's core product, ceramic capacitors [8] - Despite the challenges, the company has successfully expanded its product lines, particularly in microcontrollers and integrated circuit products, which have seen rapid revenue growth [8] - The company completed the acquisition of Chengdu Rongwei, enhancing its capabilities in microwave module components and electronic components [8] - The company has maintained stable operating cash flow, with a net operating cash flow of 459 million yuan, indicating solid liquidity management [8] Financial Summary - For 2024, the total revenue is projected to be 1.492 billion yuan, with a net profit of 154 million yuan [1][9] - The gross margin is expected to decline by 15.38 percentage points to 34.29% in 2024 [8] - The earnings per share (EPS) for 2024 is estimated at 0.67 yuan, with a projected P/E ratio of 79.21 [1][9] - The company anticipates a recovery in military electronic business, which may lead to a rebound in the market [8] - Future profit forecasts have been adjusted, with net profits expected to be 326 million yuan in 2025 and 481 million yuan in 2026 [8]

证券代码：603267 证券简称：鸿远电子 公告编号：临 2025-014 北京元六鸿远电子科技股份有限公司 关于提请股东会授权董事会以简易程序 向特定对象发行股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次授权事项概述 北京元六鸿远电子科技股份有限公司（以下简称"公司"）于 2025 年 3 月 27 日召开第三届董事会第十八次会议审议通过了《关于提请股东会授权董事会以简 易程序向特定对象发行股票的议案》，同意提请股东会授权董事会决定以简易程 序向特定对象发行融资总额不超过人民币 3 亿元且不超过最近一年末净资产 20% 的股票，授权期限自公司 2024 年年度股东会审议通过之日起至公司 2025 年年度 股东会召开之日止。本事项尚需提交至公司 2024 年年度股东会审议。 二、本次授权事宜具体内容 现提请股东会授权董事会以简易程序向特定对象发行股票，本次授权事宜包 括但不限于以下内容： （一）确认公司是否符合以简易程序向特定对象发行股票条件 授权董事会根据《中华人民共和国公司法》《中华人民共和国证券法》 ...

北京元六鸿远电子科技股份有限公司 2024 年度 XYZH/2025BJAG1B0020 北京元六鸿远电子科技股份有限公司 北京元六鸿远电子科技股份有限公司全体股东: 审计报告 | 索引 | 项码 | | --- | --- | | 审计报告 | 1-4 | | 公司财务报表 | | | 合并资产负债表 | 1-2 | | 母公司资产负债表 | 3-4 | | 合并利润表 | 5 | | 母公司利润表 | 6 | | 合并现金流量表 | 7 | | 母公司现金流量表 | 8 | | 合并股东权益变动表 | 9-10 | | 母公司股东权益变动表 | 11-12 | | 财务报表附注 | 13-106 | 胜系申话: 言永中和会计师事务所| 北京市东城区朝阳门北大街 8 号富华大厦 A 座 9 层 ic accountants 9/F Block A. Fu No 8. Chaovangmen Beid; Donachena District, Beijin 100027. P.R.China 审计报告 一、审计意见 我们审计了北京元六鸿远电子科技股份有限公司(以下简称鸿远电子公司)财务报 表,包括 2024年 ...

北京元六鸿远电子科技股份有限公司 2024 年度 内部控制审计报告 索引 内部控制审计报告 - 联系申话: | 北京市东城区朝阳门北大街 官永中和会计师事务所 8 号富华大厦 A 座 9 层 +86 (010) 6554 2288 telenhone: 9/F. Block A. Fu Hua Man No.8. Chaovangmen Beidaiie Dongcheng District, Beijin 100027 P R China 内部控制审计报告 页码 1-2 XYZH/2025BJAG1B0021 北京元六鸿远电子科技股份有限公司 北京元六湾远电子科技股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计 了北京元六鸿远电子科技股份有限公司(以下简称鸿远电子公司)2024年12月 31日财 务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评 价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是鸿远电子公司董事 会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基 ...

北京元六鸿远电子科技股份有限公司 二、独立董事年度履职概况 2024 年度独立董事述职报告 作为北京元六鸿远电子科技股份有限公司（以下简称"公司"）的独立董事、 提名委员会召集人、审计委员会委员，在 2024 年度履职期间，本人按照《中华 人民共和国公司法》《上市公司独立董事管理办法》等相关规定，认真审慎地行 使公司和股东赋予的权利，客观、独立和公正地参与公司决策，关注公司的经营 和发展状况，与公司管理层保持沟通交流，充分发挥独立董事参与决策、监督制 衡、专业咨询的作用，维护公司整体利益和全体股东特别是中小股东合法权益。 现将 2024 年度履职情况汇报如下： 一、独立董事的基本情况 林海权，中国国籍，无境外永久居留权，1980年1月出生，博士学历。曾任 中国人民大学博士后从事金融学研究工作，最高人民法院法官，中国人民大学民 商事法律科学研究中心研究员，上海国际仲裁中心仲裁员，北京相成咨询有限公 司董事长。现任中国海事仲裁委员会仲裁员，北京仲裁委员会仲裁员，北京相成 咨询有限公司监事，公司独立董事。 作为公司的独立董事，本人未在公司担任除独立董事以外的职务，与公司之 间不存在雇佣关系、交易关系、亲属等关系，符 ...